Eli Lilly's Mounjaro joins China's national health insurance list for type 2 diabetes, enhancing accessibility amid pricing adjustments. Related diabetes therapies and market impacts examined.

Massachusetts Health Connector opens 2025 enrollment with in-person Navigator support, highlighting subsidy availability and upcoming changes in federal tax credits affecting premiums.

ACA marketplace premiums in Nebraska are expected to rise sharply in 2026 due to expiring tax credits. Many consumers face significant coverage affordability challenges as federal subsidies end.

China launches its first Commercial Health Insurance Innovative Drug List with CAR-T therapies, advancing access to innovative cancer and rare disease treatments under commercial insurance.

New York City reports a 5.4% rise in HIV cases in 2024 amid proposed federal cuts exceeding $41 million to local HIV prevention and treatment funding, highlighting ongoing health disparities and socioeconomic challenges.

As enhanced Affordable Care Act healthcare subsidies expire, telehealth programs emerge as an affordable alternative, providing key access and cost benefits for underserved and uninsured populations.

Medicare Advantage plans attract over half of Medicare enrollees but face scrutiny for claim delays and hospital network restrictions, prompting legislative transparency efforts.

The expiration of enhanced ACA subsidies in 2026 prompts urgent discussions on health insurance reform focused on premium costs, claim denial rates, and network adequacy challenges.

Insightful analysis of Obamacare health insurance premium trends with expert Michael F. Cannon from Cato Institute, exploring regulatory and market influences on future pricing.

Georgia's 2026 laws introduce increased homeowners insurance protections, health insurance digital service mandates, and shifts in behavioral health oversight impacting insurance compliance and consumer protections.